A Snapshot of the Tepezza Hearing Loss Lawsuits and How the Drug Gained FDA Approval
In January 2020, pharmaceutical giant Horizon announced that the FDA approved its drug Tepezza. The promising treatment for Thyroid Eye Disease (TED) boosted the company’s shares to 4.2%. Horizon claimed Tepezza was the first approved treatment for the autoimmune disorder which if ignored could lead to blindness. The drug was said to significantly decrease the…